chr9-12708958-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000550.3(TYRP1):c.1409-18dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.596 in 1,602,834 control chromosomes in the GnomAD database, including 310,593 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.48 ( 21667 hom., cov: 0)
Exomes 𝑓: 0.61 ( 288926 hom. )
Consequence
TYRP1
NM_000550.3 intron
NM_000550.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.918
Publications
2 publications found
Genes affected
TYRP1 (HGNC:12450): (tyrosinase related protein 1) This gene encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important role in the melanin biosynthetic pathway. Defects in this gene are the cause of rufous oculocutaneous albinism and oculocutaneous albinism type III. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 9-12708958-T-TA is Benign according to our data. Variant chr9-12708958-T-TA is described in ClinVar as Benign. ClinVar VariationId is 256643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TYRP1 | ENST00000388918.10 | c.1409-19_1409-18insA | intron_variant | Intron 7 of 7 | 1 | NM_000550.3 | ENSP00000373570.4 |
Frequencies
GnomAD3 genomes AF: 0.482 AC: 73149AN: 151718Hom.: 21667 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
73149
AN:
151718
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.508 AC: 125401AN: 246804 AF XY: 0.508 show subpopulations
GnomAD2 exomes
AF:
AC:
125401
AN:
246804
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.608 AC: 882367AN: 1450998Hom.: 288926 Cov.: 31 AF XY: 0.599 AC XY: 432924AN XY: 722520 show subpopulations
GnomAD4 exome
AF:
AC:
882367
AN:
1450998
Hom.:
Cov.:
31
AF XY:
AC XY:
432924
AN XY:
722520
show subpopulations
African (AFR)
AF:
AC:
6234
AN:
33190
American (AMR)
AF:
AC:
19573
AN:
44390
Ashkenazi Jewish (ASJ)
AF:
AC:
14665
AN:
26006
East Asian (EAS)
AF:
AC:
175
AN:
39542
South Asian (SAS)
AF:
AC:
22959
AN:
85928
European-Finnish (FIN)
AF:
AC:
37851
AN:
52948
Middle Eastern (MID)
AF:
AC:
2516
AN:
5744
European-Non Finnish (NFE)
AF:
AC:
745175
AN:
1103338
Other (OTH)
AF:
AC:
33219
AN:
59912
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
14774
29547
44321
59094
73868
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18526
37052
55578
74104
92630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.482 AC: 73152AN: 151836Hom.: 21667 Cov.: 0 AF XY: 0.474 AC XY: 35215AN XY: 74234 show subpopulations
GnomAD4 genome
AF:
AC:
73152
AN:
151836
Hom.:
Cov.:
0
AF XY:
AC XY:
35215
AN XY:
74234
show subpopulations
African (AFR)
AF:
AC:
8506
AN:
41466
American (AMR)
AF:
AC:
6472
AN:
15208
Ashkenazi Jewish (ASJ)
AF:
AC:
1905
AN:
3464
East Asian (EAS)
AF:
AC:
57
AN:
5158
South Asian (SAS)
AF:
AC:
1124
AN:
4818
European-Finnish (FIN)
AF:
AC:
7577
AN:
10566
Middle Eastern (MID)
AF:
AC:
133
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45886
AN:
67848
Other (OTH)
AF:
AC:
1014
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1568
3137
4705
6274
7842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
484
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oculocutaneous albinism type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.